Optimal ketamine dosage for laryngeal mask airway insertion when co-administered with 2mg/kg propofol: a prospective, randomized, double-blinded study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008271

Enrollment

Unknown

Registered

2016-04-12

Start date

2016-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric surgery

Interventions

group K1:1.0mg/kg ketamine

group K2:1.5mg/kg ketamine

group K3:2.0mg/kg ketamine

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 90 pediatric patients, ASA class of I and II, weight 10kg-30kg and aged 3-7, who were scheduled for a short surgical procedure were enrolled

Exclusion criteria

Exclusion criteria: 1. children weight greater than 30kg or more than standard weight 20%; 2. children with neuromuscular diseases or psychiatric disorders; 3. hyper-reactive airway disease, asthma or difficult airway; 4. full stomach or risk of regurgitation and aspiration; 5. allergic to egg or milk; 6. children taking sedative drugs within 24h before entering the operating room; 7. children without the upper extremity venous pathway.

Design outcomes

Primary

Measure	Time frame
C) LMA insertion score;	—

Secondary

Measure	Time frame
recovery time;	—

Countries

China

Contacts

Public ContactYuan Tan

Shengjing Hospital of China Medical University

zhaogy7383@163.com+86 18940257383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026